CRISPR Therapeutics AG - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
CRSP Nasdaq 2836 www.crisprtx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for CRISPR Therapeutics AG

Is CRISPR Therapeutics (CRSP) One Of The Under-The-Radar Stocks With Massive Upside For 2026? - May 29th, 2026 4:31 am
CRISPR Therapeutics to Participate in Upcoming Investor Conferences - May 28th, 2026 6:00 am
Better Gene-Editing Stock: CRISPR Therapeutics or Beam Therapeutics? - May 25th, 2026 6:55 pm
Assessing CRISPR Therapeutics (CRSP) Valuation After Narrower Q1 2026 Loss And Pipeline Progress - May 24th, 2026 9:10 am
CRISPR Therapeutics AG (CRSP) Reports Q1 2026 Results - May 22nd, 2026 10:49 pm
[Latest] Global Genome Editing Market Size/Share Worth USD 55.7 Billion by 2035 at a 17.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - May 21st, 2026 11:30 am
Can Intellia's Pipeline Push Drive Long-Term Growth Amid Rivalry? - May 19th, 2026 9:53 am
CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know - May 19th, 2026 7:00 am
CRISPR Therapeutics Enters Second Phase As CASGEVY Uptake And Data Build - May 18th, 2026 12:11 am
CRISPR Therapeutics Enters 'Second Phase' as CASGEVY Momentum Builds, Pipeline Data Looms - May 15th, 2026 6:12 pm
1 Top Wall Street Analyst Thinks CRISPR Therapeutics Could More Than Double. Should You Buy the Stock Hand Over Fist? - May 11th, 2026 2:35 pm
VRTX's Alyftrek, Journavx & Casgevy See Strong Momentum in Q1 Earnings - May 8th, 2026 11:17 am
CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It - May 8th, 2026 7:00 am
Is It Time To Reconsider CRISPR Therapeutics (CRSP) After A 58% One Year Rally? - May 6th, 2026 7:17 am
CRISPR Therapeutics to Present at the Bank of America Securities 2026 Global Healthcare Conference - May 6th, 2026 6:30 am
VRTX's Q1 Earnings Beat Estimates, New Products Aid Sales Growth - May 5th, 2026 10:57 am
CRISPR Therapeutics' Q1 Loss Wider Than Expected, Sales Miss Estimates - May 5th, 2026 6:19 am
CRISPR Therapeutics AG (CRSP) Reports Q1 Loss, Lags Revenue Estimates - May 4th, 2026 5:30 pm
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results - May 4th, 2026 2:30 pm
What's the Next Big Thing After GLP-1 Drugs? CRISPR Therapeutics May Have the Answer. - Apr 30th, 2026 3:30 am